Kasey Gildersleeve, MD
Neurology · Houston, TXNPI 1790012870
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Abbott accounts for 93.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $10,141 and has fallen 98.1% since, to $196 in 2025.
Across 145 payments — averaging $172.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$23K
- AbbVie$688
- AstraZeneca$630
- Acadia Pharmaceuticals Inc$65
- Johnson & Johnson$61
- Amgen$50
- plus $204 from 8 others
Across 15 payments — averaging $3410.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$51K
What the payments were for
- Consulting fees$10,40042%
- Speaking & faculty fees$8,37533%
- Travel & lodging$2,85911%
- Food & beverage$3,40414%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 50 | $23,339 |
| AbbVie(2 entities) | 36 | $688 |
| AstraZeneca(2 entities) | 39 | $630 |
| Acadia Pharmaceuticals Inc | 3 | $65 |
| Johnson & Johnson(2 entities) | 2 | $61 |
| Amgen(2 entities) | 3 | $50 |
| Genentech USA, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $32 |
| Grifols USA, LLC | 2 | $31 |
| Assertio Therapeutics, Inc. | 2 | $25 |
| Novartis | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Medtronic | 1 | $17 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER Occluders$6,892
- Confirm Rx$4,547
- Amplatzer Cardiac Plug$3,966
- ALLURE$3,561
- JOT DX$3,000
- AMPLATZER$413
- AMPLATZER TorqVue Delivery Systm$169
- AMPLATZER AMULET$162
- MitraClip System$138
How this compares
$25,038 in reported general payments places this provider in the 85th percentile of 1,246 neurology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Houston
- William OndoHouston$1.4M
- Pankaj SatijaHouston$1.1M
- Annette HowardHouston$826K
- Randolph EvansHouston$493K
- Leorah FreemanHouston$401K
- Mazen DimachkieHouston$388K
- Zsila SadighiHouston$361K
- Joseph JankovicHouston$323K
- Raja MehannaHouston$300K
- Eddie PattonHouston$299K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.